GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Cyclically Adjusted FCF per Share

Glycorex Transplantation AB (NGM:GTAB B) Cyclically Adjusted FCF per Share : kr-0.01 (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Glycorex Transplantation AB's adjusted free cash flow per share for the three months ended in Mar. 2025 was kr0.019. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-0.01 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-05-31), Glycorex Transplantation AB's current stock price is kr2.29. Glycorex Transplantation AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr-0.01. Glycorex Transplantation AB's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Glycorex Transplantation AB was 444.00. The lowest was 390.00. And the median was 407.50.


Glycorex Transplantation AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Glycorex Transplantation AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Cyclically Adjusted FCF per Share Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.01 -0.01 -0.01

Glycorex Transplantation AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 - -0.01 -0.01

Competitive Comparison of Glycorex Transplantation AB's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Glycorex Transplantation AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glycorex Transplantation AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Glycorex Transplantation AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Glycorex Transplantation AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Glycorex Transplantation AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.019/132.8245*132.8245
=0.019

Current CPI (Mar. 2025) = 132.8245.

Glycorex Transplantation AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.025 99.995 -0.033
201509 -0.017 100.228 -0.023
201512 0.019 100.276 0.025
201603 0.012 100.751 0.016
201606 0.013 101.019 0.017
201609 -0.024 101.138 -0.032
201612 0.040 102.022 0.052
201703 -0.006 102.022 -0.008
201706 -0.007 102.752 -0.009
201709 0.011 103.279 0.014
201712 0.041 103.793 0.052
201803 -0.012 103.962 -0.015
201806 0.008 104.875 0.010
201809 -0.015 105.679 -0.019
201812 0.037 105.912 0.046
201903 -0.012 105.886 -0.015
201906 0.014 106.742 0.017
201909 0.068 107.214 0.084
201912 0.014 107.766 0.017
202003 0.035 106.563 0.044
202006 -0.062 107.498 -0.077
202009 0.023 107.635 0.028
202012 -0.005 108.296 -0.006
202103 -0.039 108.360 -0.048
202106 0.006 108.928 0.007
202109 0.006 110.338 0.007
202112 -0.016 112.486 -0.019
202203 -0.055 114.825 -0.064
202206 0.015 118.384 0.017
202209 -0.009 122.296 -0.010
202212 0.012 126.365 0.013
202303 -0.055 127.042 -0.058
202306 -0.063 129.407 -0.065
202309 -0.038 130.224 -0.039
202312 -0.021 131.912 -0.021
202403 -0.001 132.205 -0.001
202406 -0.026 132.716 -0.026
202409 0.014 132.304 0.014
202412 0.014 132.987 0.014
202503 0.019 132.825 0.019

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Glycorex Transplantation AB  (NGM:GTAB B) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Glycorex Transplantation AB was 444.00. The lowest was 390.00. And the median was 407.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Glycorex Transplantation AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Glycorex Transplantation AB Business Description

Traded in Other Exchanges
Address
Solvegatan 41, Lund, SWE, 223 70
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines